Welcome back to another Managed Healthcare Executive Between the Lines series. In this opening episode, moderator Philip Mease, MD, Director of Rheumatology Research at Swedish Medical Center, Providence St. Joseph Health, and Clinical Professor at the University of Washington, is joined by Saakshi Khattri, MD, Director of the Center for Connective Tissue Diseases at the Icahn School of Medicine at Mount Sinai, to lay the groundwork for a discussion on the BE BOLD head-to-head trial of bimekizumab versus risankizumab in active psoriatic arthritis (PSA).